Cargando…

RHOA in Gastric Cancer: Functional Roles and Therapeutic Potential

The well-known signal mediator and small GTPase family member, RHOA, has now been associated with the progression of specific malignancies. In this review, we appraise the biomedical literature regarding the role of this enzyme in gastric cancer (GC) signaling, suggesting potential clinical signific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nam, Seungyoon, Kim, Jung Ho, Lee, Dae Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529512/ https://www.ncbi.nlm.nih.gov/pubmed/31156701 http://dx.doi.org/10.3389/fgene.2019.00438

Ejemplares similares

RHOA protein expression correlates with clinical features in gastric cancer: a systematic review and meta-analysis
por: Nam, Seungyoon, et al.
Publicado: (2022)

Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer
por: Chang, Hae Ryung, et al.
Publicado: (2016)

Second-Generation JK-206 Targets the Oncogenic Signal Mediator RHOA in Gastric Cancer
por: Beak, Myeonghun, et al.
Publicado: (2022)

NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer
por: Murray, D, et al.
Publicado: (2008)

Potential long non-coding RNAs to be considered as biomarkers or therapeutic targets in gastric cancer
por: Hajjari, Mohammadreza, et al.
Publicado: (2013)

Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer
por: Dopeso, Higinio, et al.
Publicado: (2018)

Identification of New Therapeutic Targets for Gastric Cancer With Bioinformatics
por: Li, Yang, et al.
Publicado: (2020)

A Deep Learning Model for Cell Growth Inhibition IC50 Prediction and Its Application for Gastric Cancer Patients
por: Joo, Minjae, et al.
Publicado: (2019)

HER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer
por: Han, Sanghoon, et al.
Publicado: (2020)

DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer
por: Zeng, Yunqing, et al.
Publicado: (2022)

Genome-Scale Metabolic Model Analysis of Metabolic Differences between Lauren Diffuse and Intestinal Subtypes in Gastric Cancer
por: Nam, Seungyoon, et al.
Publicado: (2022)

RHOA Therapeutic Targeting in Hematological Cancers
por: Santos, Juliana Carvalho, et al.
Publicado: (2023)

Systematic review of gastric cancer-associated genetic variants, gene-based meta-analysis, and gene-level functional analysis to identify candidate genes for drug development
por: Lee, Sangjun, et al.
Publicado: (2022)

Identification and Verification of Potential Biomarkers in Gastric Cancer By Integrated Bioinformatic Analysis
por: Sun, Chenyu, et al.
Publicado: (2022)

Comparison of Microbiota Variation in Korean Healthy Adolescents with Adults Suggests Notable Maturity Differences
por: Kim, Joo-Wook, et al.
Publicado: (2018)

Role of Prohibitins in Aging and Therapeutic Potential Against Age-Related Diseases
por: Belser, Misa, et al.
Publicado: (2021)

DNA Damage Repair and Current Therapeutic Approaches in Gastric Cancer: A Comprehensive Review
por: Wang, Menghui, et al.
Publicado: (2022)

Lipid metabolism characterization in gastric cancer identifies signatures to predict prognostic and therapeutic responses
por: Zeng, Jiawei, et al.
Publicado: (2022)

Case Report: Pathogenesis With a Rare RHOA A161E Mutation in a Patient With Angioimmunoblastic T-Cell Lymphoma
por: Cao, Lihong, et al.
Publicado: (2022)

DNA computing for gastric cancer analysis and functional classification
por: Chen, Congzhou, et al.
Publicado: (2022)

PLCE1 Polymorphisms Are Associated With Gastric Cancer Risk: The Changes in Protein Spatial Structure May Play a Potential Role
por: Hu, Xi’e, et al.
Publicado: (2021)

Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis
por: Niu, Xiaoji, et al.
Publicado: (2022)

Phospholipid Scramblases: Role in Cancer Progression and Anticancer Therapeutics
por: Behuria, Himadri Gourav, et al.
Publicado: (2022)

NALCN is a potential biomarker and therapeutic target in human cancers
por: He, Jian, et al.
Publicado: (2023)

Clinical Relevance and Molecular Phenotypes in Gastric Cancer, of TP53 Mutations and Gene Expressions, in Combination With Other Gene Mutations
por: Park, Sungjin, et al.
Publicado: (2016)

Differential gene expression pattern in early gastric cancer by an integrative systematic approach
por: NAM, SEUNGYOON, et al.
Publicado: (2012)

Immune regulation in gastric adenocarcinoma is linked with therapeutic efficacy and improved recovery
por: Xu, Zhenglei, et al.
Publicado: (2023)

Identification of Potential Prognostic Biomarkers Associated With Macrophage M2 Infiltration in Gastric Cancer
por: Liu, Baohong, et al.
Publicado: (2022)

Common Core Genes Play Vital Roles in Gastric Cancer With Different Stages
por: Yu, Zhiyuan, et al.
Publicado: (2022)

Editorial: RNA Modification in Human Cancers: Roles and Therapeutic Implications
por: Zhou, You, et al.
Publicado: (2022)

Systematic mutation analysis in rare colorectal cancer presenting ovarian metastases
por: Park, Sungjin, et al.
Publicado: (2019)

BGN May be a Potential Prognostic Biomarker and Associated With Immune Cell Enrichment of Gastric Cancer
por: Zhang, Shiyu, et al.
Publicado: (2022)

Dissecting the Role of Immune Checkpoint Regulation Patterns in Tumor Microenvironment and Prognosis of Gastric Cancer
por: Zhen, Zili, et al.
Publicado: (2022)

REV1: A novel biomarker and potential therapeutic target for various cancers
por: Zhu, Ning, et al.
Publicado: (2022)

Osteogenesis imperfecta: potential therapeutic approaches
por: Rousseau, Maxime, et al.
Publicado: (2018)

Characterization of Platelet Function-Related Gene Predicting Survival and Immunotherapy Efficacy in Gastric Cancer
por: Xia, Yan, et al.
Publicado: (2022)

Identification of Potential Key Genes Associated With the Pathogenesis and Prognosis of Gastric Cancer Based on Integrated Bioinformatics Analysis
por: Liu, Xinkui, et al.
Publicado: (2018)

Identification of Enhancer RNA CDK6-AS1 as a Potential Novel Prognostic Biomarker in Gastric Cancer
por: Yang, Shifeng, et al.
Publicado: (2022)

Potential value of the homologous recombination deficiency signature we developed in the prognosis and drug sensitivity of gastric cancer
por: Wu, Xin, et al.
Publicado: (2022)

A novel prognostic and therapeutic target biomarker based on necroptosis-related gene signature and immune microenvironment infiltration in gastric cancer
por: Xin, Dao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o2apepi1muqoj1e5i3a64jpto9